| 摘要 |
The present invention relates to compositions and methods for treatment of proliferative disease. In specific aspects, the present invention relates to compositions including (1 R,4aS, 10aR)- 1,2,3,4,4a,9, 10, 10a-octahydro- 1 -,4a-dimethyl-7-( 1 - methylethyl)-1-phenanthrenemethanamine (leelamine) and arachidonyl trifluoromethyl ketone (ATK) in combination; methods for treatment of cancer including administration of leelamine and ATK in a subject in need thereof; and particularly methods for treatment of skin cancer including administration of leelamine and ATK in a subject in need thereof. |
